Benefits [qnco]    
Induced [ftcn]    
PLEURAL EFFUSION [dsyn]    
ASCITES [fndg]    
Percutaneous [spco]    
Radiofrequency Ablation [topp]    
HEPATOCELLULAR CARCINOMA [neop]    
Hepatic surface [blor]    
Hepatic [blor]    
dome [spco]    
Aims [idcn]    
Radiofrequency Ablation [topp]    
Artificial [qlco]    
PLEURAL EFFUSION [dsyn]    
Artificial [qlco]    
ASCITES [fndg]    
Recently [tmco]    
Useful [qlco]    
DEVICE [medd]    
treatment [ftcn]    
HEPATOCELLULAR CARCINOMA [neop]    
indication [idcn]    
Technique [ftcn]    
Therapeutic Efficacy [qlco]    
Undetermined [idcn]    
methodology [inpr]    
Precision [tmco]    
indication [idcn]    
Artificial [qlco]    
Infusion [topp]    
Artificial [qlco]    
PLEURAL EFFUSION [dsyn]    
Indicated [fndg]    
Tumors [neop]    
DORSAL [spco]    
Side [spco]    
Hepatic surface [blor]    
RIGHT [spco]    
Lobe [bpoc]    
Artificial [qlco]    
ASCITES [fndg]    
Indicated [fndg]    
I-TUMOR [ftcn]    
VENTRAL [spco]    
Side [spco]    
Hepatic surface [blor]    
RIGHT [spco]    
Lobe [bpoc]    
Tumors [neop]    
Completely [qlco]    
Visualized [ftcn]    
Hepatic surface [blor]    
RIGHT [spco]    
Lobe [bpoc]    
III [inpr]    
Tumors [neop]    
Hepatic surface [blor]    
Adjacent [spco]    
organs [bpoc]    
LOCAL [spco]    
> 2 years [fndg]    
Estimated [qnco]    
Survival Rates [qnco]    
Patients [podg]    
YEARS [tmco]    
>90 [qnco]    
LOCAL [spco]    
Tumour size [spco]    
YEARS [tmco]    
Conclusions [idcn]    
Radiofrequency Ablation [topp]    
Artificial [qlco]    
PLEURAL EFFUSION [dsyn]    
ASCITES [fndg]    
effective [qlco]    
Tumors [neop]    
Hepatic surface [blor]    
Hepatic [blor]    
dome [spco]    
